Lineage Cell Therapeutics, Inc. (LCTX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-02

Lineage Cell Therapeutics, Inc. (LCTX) has filed 6 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. 2 Form 8-K material event filings were reported by LCTX in the last 90 days. InsiderAlpha tracks every LCTX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Lineage Cell Therapeutics, Inc. (LCTX)

SEC CIK0000876343

90-Day SEC Filing Activity

Form 4 filings (90d)6
Form 8-K filings (90d)2
Latest Form 4 filing2026-07-02

Recent LCTX Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Culley Brian MPresident and CEOP — Open-market purchase15.0K$1.62$24KSEC
Samuel George A. IIIGeneral Counsel and SecretaryF — Tax withholding / forfeiture2.5K$1.80$5KSEC
Culley Brian MPresident and CEOF — Tax withholding / forfeiture12.9K$1.80$23KSEC
Samuel George A. IIIGeneral Counsel and SecretaryM — Option exercise6.1K——SEC
Culley Brian MPresident and CEOM — Option exercise31.2K——SEC
Samuel George A. IIIGeneral Counsel and SecretaryA — Grant or award1.7K——SEC
Culley Brian MPresident and CEOA — Grant or award8.9K——SEC
Culley Brian MPresident and CEOF — Tax withholding / forfeiture334$1.68$561SEC
Samuel George A. IIIGeneral Counsel and SecretaryF — Tax withholding / forfeiture65$1.68$109SEC
Howe Jill AnnChief Financial OfficerP — Open-market purchase15.0K$0.59$9KSEC
Samuel George A. IIIGeneral CounselP — Open-market purchase15.0K$0.60$9KSEC
Mulroy Michael H.InsiderP — Open-market purchase40.0K$0.57$23KSEC
Culley Brian MPresident and CEOP — Open-market purchase40.0K$0.60$24KSEC

All transactions sourced from SEC EDGAR Form 4 filings for Lineage Cell Therapeutics, Inc. (LCTX). Updated in real time as new filings are submitted to the SEC.

Most-Active LCTX Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
Bradsher Neal C1—
ANDREWS DEBORAH J1—
Mulroy Michael H.1—
Russell Angus C.1—
Jayasuriya Anula1—

Recent LCTX Form 8-K Material Events

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in LCTX insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

LCTX Insider Trading — FAQ

What is the latest insider trade for LCTX?
Lineage Cell Therapeutics, Inc. (LCTX) had 6 insider filings in the last 90 days, with the most recent on 2026-07-02. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying LCTX stock?
0 insider purchases of LCTX were filed in the last 90 days.
How many insiders are selling LCTX stock?
0 insider sales of LCTX were filed in the last 90 days.
Where can I see LCTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every LCTX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live LCTX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.